Effect of introducing biologics to patients with rheumatoid arthritis on the risk of venous thromboembolism: a nationwide cohort study

In the United States, 100,000–300,000 patients die from venous thromboembolism (VTE) each year, with more than 500,000 people related hospitalizations. While in Europe, 500,000 people die from VTE each year. Patients with rheumatoid arthritis are at increased risk of VTE. The use of biologics in pat...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 11; no. 1; p. 17009
Main Authors Chen, Chao-Ping, Kung, Pei-Tseng, Chou, Wen-Yu, Tsai, Wen-Chen
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 23.08.2021
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…